查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529866

皮下给药装置市场规模、份额和趋势分析报告：按产品、分销管道、地区和细分市场预测，2024-2030 年

Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Pen Injectors, Wearable Injectors), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

皮下给药装置市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球皮下给药装置市场规模预计将达到518亿美元，2024年至2030年复合年增长率为7.5%。

慢性病的盛行率不断增加，加上定期服用药物来缓解疾病症状，增加了对家庭用药设备的需求。根据美国疾病管制与预防美国(CDC) 的数据，2018 年，美国约有 5,440 万（22.7%）成年人患有关节炎、纤维肌痛、痛风或红疮。

此外，越来越多的生物製药被核准用于治疗需要大剂量或延长治疗时间的危及生命的疾病，从而加速了对皮下给药装置的需求。英国公司Informa 2019 年2 月发表的研究显示，临床试验管线中的药物总数肠胃外给药比例从2018 年的53.0% 上升至2019 年的55.0%，而口服药物製剂总体比例从2018 年的33.0%下降。

皮下给药装置市场报告亮点

  • 由于人口老化和可支配收入较高，慢性病盛行率不断上升，2023年北美地区占据最大的销售份额。
  • 从产品来看，注射笔预计在预测期内复合年增长率最高，因为它们易于管理多种药物且价格实惠。
  • 按分销管道划分，零售药房领域由于包含大型连锁药局以及新给药设备的有吸引力的计划和折扣而占据最大的市场占有率。
  • 市场参与者正在采取策略联盟和产品创新等多种策略，以满足全球市场日益增长的患者需求。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章皮下给药装置市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 皮下给药装置市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章皮下给药装置市场：产品评估与趋势分析

  • 细分仪表板
  • 皮下给药装置市场：产品波动分析
  • 皮下给药装置市场：依产品分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 预填充式注射器
  • 笔式註射器
  • 自动注射器
  • 穿戴式註射器
  • 无针注射器

第五章皮下给药装置市场：分销通路估计与趋势分析

  • 细分仪表板
  • 皮下给药装置市场：分销通路波动分析
  • 按分销管道分類的皮下给药装置市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院药房
  • 零售药房
  • 网路药房

第六章皮下给药装置市场：区域估计与趋势分析

  • 区域仪表板
  • 按地区分類的皮下给药装置市场波动分析
  • 皮下给药装置市场：按分销管道和最终用途分類的区域估计和趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
    • 2018-2030年北美皮下给药装置市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲皮下给药装置市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区皮下给药装置市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年拉丁美洲皮下给药装置市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲皮下给药装置市场估计与预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Gerresheimer AG
    • Medtronic Plc
    • Ypsomed AG
    • Elcam Medical Group
    • Novo Nordisk
    • Insulet Corporation
    • Becton, Dickinson and Company
    • West Pharmaceutical Services, Inc.
    • PharmaJet
    • Unilife Corporation
    • Inolife Sciences
Product Code: GVR-4-68039-039-7

Subcutaneous Drug Delivery Devices Market Growth & Trends:

The global subcutaneous drug delivery devices market size is expected to reach USD 51.8 billion by 2030, registering to grow at a CAGR of 7.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions combined with regular medicine administration to relive disease symptoms has enhanced the demand for in-home drug administration devices. As per the Centers for Disease Control and Prevention (CDC), in 2018, about 54.4 million adults, amounting to 22.7% suffered from arthritis, fibromyalgia, gout, or lupus in the U.S. The CDC further stated that by 2040, an estimated 78.0 million adults accounting for 26.0% will be diagnosed with arthritis.

In addition, a rising number of biologic medicine approvals for the treatment of life-threatening conditions in patients requiring large dose volumes or extended delivery periods accelerate the demand for subcutaneous drug delivery devices. According to the study published by Informa U.K., in February 2019, the total number of medicines in the clinical trial pipeline increased from 53.0% in 2018 to 55.0% in 2019 for parenteral administrations, with an overall decrease in oral medicine formulations from 33.0% in 2018 to 31.0% in 2019.

Subcutaneous Drug Delivery Devices Market Report Highlights:

  • North America accounted for the largest revenue share in 2023 owing to the rising prevalence of chronic diseases in the geriatric population and high disposable income
  • By product, injection pen is expected to register the highest CAGR during the forecast period owing to ease in providing multi-dose medicine and affordability
  • By distribution channel, the retail pharmacies segment accounted for the largest market share as they include large pharmacy chains and attractive schemes and discounts for the novel medicine delivery devices
  • Market players are adopting several strategies such as strategic collaborations and product innovations to cater to the increasing patient demand in the global market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
      • 1.2.1.1. Distribution Channel
      • 1.2.1.2. Regional scope
      • 1.2.1.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Distribution Channel outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Subcutaneous Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic diseases
      • 3.2.1.2. Increasing production of biologics
      • 3.2.1.3. Increasing product innovations and approvals
      • 3.2.1.4. Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced delivery systems
      • 3.2.2.2. Lack of awareness in developing countries
  • 3.3. Subcutaneous Drug Delivery Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Subcutaneous Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Subcutaneous Drug Delivery Devices Market: Product Movement Analysis
  • 4.3. Subcutaneous Drug Delivery Devices Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Prefilled Syringes
    • 4.5.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Pen Injectors
    • 4.6.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Auto Injectors
    • 4.7.1. Auto Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Wearable Injectors
    • 4.8.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Needle-free Injectors
    • 4.9.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Subcutaneous Drug Delivery Devices Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Subcutaneous Drug Delivery Devices Market: Distribution Channel Movement Analysis
  • 5.3. Subcutaneous Drug Delivery Devices Market by Distribution Channel Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospital Pharmacies
    • 5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Retail Pharmacies
    • 5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Online Pharmacies
    • 5.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Subcutaneous Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional Subcutaneous Drug Delivery Devices Market Movement Analysis
  • 6.3. Subcutaneous Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. U.S. Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Canada Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. Mexico Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. UK Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Germany Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. France Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Italy Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Spain Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Denmark Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Sweden Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Reimbursement scenario
      • 6.6.9.5. Norway Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Japan
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Japan Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. China
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. China Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. India
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. India Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Australia
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Australia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Thailand Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Latin America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Brazil Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Argentina Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Middle East & Africa
    • 6.9.1. Middle East & Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. South Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Saudi Arabia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.4. UAE
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. UAE Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Reimbursement scenario
      • 6.9.5.5. Kuwait Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Gerresheimer AG
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Medtronic Plc
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Ypsomed AG
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Elcam Medical Group
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Novo Nordisk
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Insulet Corporation
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Becton, Dickinson and Company
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. West Pharmaceutical Services, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. PharmaJet
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Unilife Corporation
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Inolife Sciences
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 5 North America subcutaneous drug delivery devices market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 8 U.S. subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 10 Canada subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Europe subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 UK subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Germany subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 France subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 France subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 Italy subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Spain subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Norway subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 29 Sweden subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Denmark subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Japan subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38 China subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 39 China subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 India subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 41 India subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Australia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 South Korea subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Thailand subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Latin America subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 Brazil subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Brazil subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 Argentina subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 South Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 UAE subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64 Kuwait subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Subcutaneous drug delivery devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Subcutaneous drug delivery devices market, product outlook key takeaways (USD Million)
  • Fig. 12 Subcutaneous drug delivery devices market product movement analysis 2023 & 2030 (USD Million)
  • Fig. 13 Prefilled syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Auto injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Subcutaneous drug delivery devices market, distribution channel outlook key takeaways (USD Million)
  • Fig. 19 Subcutaneous drug delivery devices market, distribution channel movement analysis 2023 & 2030 (USD Million)
  • Fig. 20 Hospital pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Retail pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Online pharmacies market, application outlook key takeaways (USD Million)
  • Fig. 23 Subcutaneous drug delivery devices market: Regional key takeaways (USD Million)
  • Fig. 24 Subcutaneous drug delivery devices market regional outlook, 2023 & 2030, USD Million
  • Fig. 25 North America subcutaneous drug delivery devices estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 US subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Italy subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Japan subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Australia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 List of key emerging company's/distribution channel disruptors/innovators